Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

SELL
$0.0 - $12.8 $0 - $928,000
-72,500 Reduced 45.62%
86,406 $987,000
Q2 2022

Aug 15, 2022

BUY
$5.28 - $18.9 $384,162 - $1.38 Million
72,758 Added 84.46%
158,906 $1.18 Million
Q1 2022

May 16, 2022

BUY
$12.92 - $27.18 $633,648 - $1.33 Million
49,044 Added 132.18%
86,148 $1.51 Million
Q4 2021

Feb 14, 2022

BUY
$21.96 - $42.69 $184,925 - $359,492
8,421 Added 29.36%
37,104 $978,000
Q3 2021

Nov 15, 2021

SELL
$41.3 - $54.56 $215,090 - $284,148
-5,208 Reduced 15.37%
28,683 $1.21 Million
Q2 2021

Aug 16, 2021

BUY
$38.61 - $55.0 $201,235 - $286,660
5,212 Added 18.17%
33,891 $1.84 Million
Q1 2021

May 17, 2021

BUY
$38.1 - $59.09 $739,025 - $1.15 Million
19,397 Added 208.97%
28,679 $1.3 Million
Q4 2020

Feb 16, 2021

BUY
$33.26 - $59.72 $308,719 - $554,321
9,282 New
9,282 $404,000

Others Institutions Holding ACCD

About Accolade, Inc.


  • Ticker ACCD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 71,938,896
  • Market Cap $496M
  • Description
  • Accolade, Inc., together with its subsidiaries, develops and provides technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based technology and multimodal support from a team of health assistants and cli...
More about ACCD
Track This Portfolio

Track Man Group PLC Portfolio

Follow Man Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Man Group PLC with notifications on news.